WSB1 and prostate cancer: Taken together with the previously reported association between elevated WSB1 expression and high tumor grade, these survival data demonstrated that WSB1 overexpression was correlated with unfavorable prognosis, suggesting WSB1 as a clinical biomarker for prostate cancer.